Doherty; James B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Doherty; James B..The latest application filed is for "p38 kinase inhibiting agents".

Company Profile

0.20.21

Doherty; James B. - Montvale NJ
Doherty; James B. - Montebello NY
Doherty; James B. - Rahway NJ
Doherty; James B. - Montale NJ
Doherty; James B. - Montvae NJ
Doherty, James B - Montvale NJ
Doherty; James B. - New Milford NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
P38 Kinase Inhibiting Agents App 20110183959 - Chen; Meng-Hsin ; et al.	2011-07-28
P38 kinase inhibiting agents Grant 7,879,875 - Chen , et al. February 1, 2	2011-02-01
Novel Azetidinones Useful As Inhibitors Of Elastase App 20100216761 - Doherty; James B. ; et al.	2010-08-26
Ophthalmic Compositions for Treating Ocular Hypertension App 20090281154 - Doherty; James B. ; et al.	2009-11-12
Ophthalmic compositions for treating ocular hypertension Grant 7,576,122 - Shen , et al. August 18, 2	2009-08-18
Ophthalmic compositions for treating ocular hypertension Grant 7,563,816 - Doherty , et al. July 21, 2	2009-07-21
Ophthalmic compositions for treating ocular hypertension Grant 7,547,720 - Doherty , et al. June 16, 2	2009-06-16
P38 Kinase Inhibiting Agents App 20090131472 - Chen; Meng-Hsin ; et al.	2009-05-21
Ophthalmic compositions for treating ocular hypertension Grant 7,528,163 - Doherty , et al. May 5, 2	2009-05-05
P38 Kinase Inhibiting Agents App 20090088436 - Chen; Meng-Hsin ; et al.	2009-04-02
Ophthalmic Compositions for Treating Ocular Hypertension App 20090062280 - Doherty; James B. ; et al.	2009-03-05
Ophthalmic compositions for treating ocular hypertension Grant 7,494,983 - Chen , et al. February 24, 2	2009-02-24
P38 kinase inhibiting agents Grant 7,482,345 - Chen , et al. January 27, 2	2009-01-27
Ophthalmic compositions for treating ocular hypertension App 20080287489 - Shen; Dong-Ming ; et al.	2008-11-20
Ophthalmic compositions for treating ocular hypertension Grant 7,410,992 - Chen , et al. August 12, 2	2008-08-12
Ophthalmic Compositions For Treating Ocular Hypertension App 20080032951 - Doherty; James B. ; et al.	2008-02-07
(Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents Grant 7,314,873 - Doherty , et al. January 1, 2	2008-01-01
P38 kinase inhibiting agents App 20070129372 - Chen; Meng-Hsin ; et al.	2007-06-07
Ophthalmic compositions for treating ocular hypertension App 20070129418 - Doherty; James B. ; et al.	2007-06-07
Ophthalmic compositions for treating ocular hypertension Grant 7,196,082 - Doherty , et al. March 27, 2	2007-03-27
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds Grant 7,196,095 - Biftu , et al. March 27, 2	2007-03-27
Ophthalmic compositions for treating ocular hypertension App 20070027188 - Chen; Meng Hsin ; et al.	2007-02-01
Ophthalmic compositions for treating ocular hypertension App 20070010491 - Chen; Meng Hsin ; et al.	2007-01-11
Ophthalmic compositions for treating ocular hypertension App 20060276504 - Shen; Dong-Ming ; et al.	2006-12-07
Ophthalmic compositions for treating ocular hypertension App 20060154897 - Doherty; James B. ; et al.	2006-07-13
Opthalmic compositions for treating ocular hypertension App 20060148805 - Chen; Meng Hsin ; et al.	2006-07-06
Ophthalmic compositions for treating ocular hypertension App 20060020000 - Doherty; James B. ; et al.	2006-01-26
Ophthalmic compositions for treating ocular hypertension App 20050256117 - Chen, Meng Hsin ; et al.	2005-11-17
(Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents App 20050176723 - Doherty, James B ; et al.	2005-08-11
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents Grant 6,809,199 - Doherty , et al. October 26, 2	2004-10-26
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds App 20040176396 - Biftu, Tesfaye ; et al.	2004-09-09
Ophthalmic compositions for treating ocular hypertension App 20040097575 - Doherty, James B. ; et al.	2004-05-20
(Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents App 20030092712 - Doherty, James B. ; et al.	2003-05-15
Substituted azetidinones as anti-inflammatory and antidegenerative agents Grant 5,591,737 - Doherty , et al. January 7, 1	1997-01-07
Substituted azetidinones as anti-inflammatory and antidegenerative agents Grant 5,229,381 - Doherty , et al. July 20, 1	1993-07-20
Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents Grant 5,132,301 - Doherty , et al. July 21, 1	1992-07-21
Substituted cephalosporins as anti-inflammatory and antidegenerative agents Grant 4,637,999 - Doherty , et al. January 20, 1	1987-01-20
Substituted cephalosporin sulfoxides as anti-inflammatory and antidegenerative agents Grant 4,623,645 - Doherty , et al. November 18, 1	1986-11-18
Substituted cephalosporin sulfones as anti-inflammatory and anti-degenerative agents Grant 4,547,371 - Doherty , et al. October 15, 1	1985-10-15
1-Carbapenem-3-carboxylic esters as anti-inflammatory agents Grant 4,493,839 - Doherty , et al. January 15, 1	1985-01-15
Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation Grant 4,368,190 - Shen , et al. January 11, 1	1983-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.